Latest Regulatory News

ACDC Metals has reported a substantial upgrade to its Goschen Central Project, increasing mineral resource tonnes by over 60% and enhancing rare earth element grades, supported by Victorian government initiatives.

Evion Group has initiated shipments from its expandable graphite joint venture in India, securing initial sales of A$2 million, while making significant progress on mining licenses and community support for its Maniry Graphite Project in Madagascar.

HyTerra Ltd has solidified its position in the emerging white hydrogen sector with a strategic A$21.9 million investment from Fortescue and significant expansion of its Nemaha Project acreage in Kansas. Preparations for a major drilling campaign are underway, signaling accelerated exploration activity in 2025.

Lake Resources NL reported a robust cash position of AUD 22.56 million for Q4 2024, bolstered by a $13.6 million sale of non-core assets and steady progress on the Kachi lithium project’s environmental and engineering milestones.

OzAurum Resources reports a dynamic quarter with fresh drilling targets at Mulgabbie, high-grade gold at Patricia, and promising niobium anomalies in Brazil, supported by a $1 million capital raise.

InteliCare advances its AI-driven platform deployment across multiple Hardi Aged Care sites, while expanding its commercial pipeline and enhancing product capabilities.

InteliCare Holdings Limited reported a positive net cash flow of $30,000 for the December quarter, buoyed by a substantial government R&D rebate. The company ends the quarter with $1.26 million in cash, signaling operational stability amid ongoing funding evaluations.

Black Dragon Gold's rezoning application for its flagship Salave Gold Project was rejected by local authorities, posing challenges for mining development. Meanwhile, the company secured a strategic placement raising AUD$712,000 to support ongoing operations.

Miramar Resources Limited (ASX: M2R) has been suspended from ASX quotation following a trading halt due to an undisclosed market-sensitive announcement. The suspension aims to prevent disorderly trading until clarity is provided.

Amplia Therapeutics reports encouraging progress in its Phase 2a ACCENT trial for pancreatic cancer, with nine confirmed partial responses and ongoing patient recruitment. The company also strengthens its financial position with a $13 million capital raise to support further clinical development.

Sky Metals has reported strong progress at its Tallebung tin project, completing surface trenching and initiating bulk sampling to validate resource estimates and optimise metallurgical processes. A recent $6 million capital raise will fund expanded drilling and development studies, positioning the company for near-term growth.

Altair Minerals Limited has voluntarily suspended trading of its shares pending a significant announcement about a proposed project acquisition, expected before markets open on February 3, 2025.